Biocartis Group (Belgium) Today
| BCART Stock | EUR 0.29 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 70
|
Biocartis Group is trading at 0.29 as of the 18th of April 2024, a No Change since the beginning of the trading day. The stock's open price was 0.29. Biocartis Group has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Biocartis Group NV are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of April 2022 and ending today, the 18th of April 2024. Click here to learn more.
Biocartis Group NV, a molecular diagnostics company, provides diagnostic solutions enhancing clinical practice for the benefit of patients, clinicians, payers, and healthcare industry with a focus on oncology. The company was founded in 2007 and is headquartered in Mechelen, Belgium. The company has 93.1 M outstanding shares. More on Biocartis Group NV
Biocartis Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Biocartis Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Biocartis Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Health Care Equipment & Supplies, Diagnostics & Research, Healthcare (View all Sectors) |
Biocartis Group NV (BCART) is traded on Euronext Brussels in Belgium and employs 619 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 60.8 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biocartis Group's market, we take the total number of its shares issued and multiply it by Biocartis Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Biocartis Group NV operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 93.1 M outstanding shares.
Biocartis Group NV has accumulated about 53.52 M in cash with (65.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.93, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Biocartis Group Probability Of Bankruptcy
Ownership AllocationBiocartis Group NV retains a total of 93.1 Million outstanding shares. Biocartis Group NV shows 6.66 percent of its outstanding shares held by insiders and 27.706 percent owned by other corporate entities. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Biocartis Ownership Details
Biocartis Stock Against Markets
Picking the right benchmark for Biocartis Group stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Biocartis Group stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Biocartis Group is critical whether you are bullish or bearish towards Biocartis Group NV at a given time. Please also check how Biocartis Group's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Biocartis Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Biocartis Group Corporate Management
Elected by the shareholders, the Biocartis Group's board of directors comprises two types of representatives: Biocartis Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biocartis. The board's role is to monitor Biocartis Group's management team and ensure that shareholders' interests are well served. Biocartis Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biocartis Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Reginald Genechten | Head Chain | Profile | |
| Benoit Devogelaere | Chief Officer | Profile | |
| Erwin Sablon | Head Management | Profile | |
| Geert Maertens | Chairman Officer | Profile | |
| JeanMarc Roelandt | Chief Officer | Profile | |
| Piet Houwen | Chief Officer | Profile | |
| Renate Degrave | Head Communications | Profile |
How to buy Biocartis Stock?
Before investing in Biocartis Group, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Biocartis Group. To buy Biocartis Group stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Biocartis Group. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Biocartis Group stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Biocartis Group NV stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Biocartis Group NV stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Biocartis Group NV, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Biocartis Group NV?
The danger of trading Biocartis Group NV is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Biocartis Group is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Biocartis Group. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Biocartis Group NV is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biocartis Group NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Biocartis Stock analysis
When running Biocartis Group's price analysis, check to measure Biocartis Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocartis Group is operating at the current time. Most of Biocartis Group's value examination focuses on studying past and present price action to predict the probability of Biocartis Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biocartis Group's price. Additionally, you may evaluate how the addition of Biocartis Group to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |